| Breast Cancer News From Medical News Today |
Latest Trial Against Wyeth Hormone Drug Starts In Philadelphia The latest court case exploring the link between Wyeth Pharmaceuticals' hormonal replacement drug Prempro and breast cancer started Tuesday in Philadelphia, the Philadelphia Inquirer reports... |
Researchers Report Developments In Breast, Ovarian Cancer Detection Researchers recently identified several genetic variations associated with breast cancer, while a Belgian company announced the success of an experimental test to detect ovarian tumors. Summaries appear below. ~ Breast cancer: A team of British and French researchers recently identified "a suite of 14 genetic variations" that are related to breast cancer, Time reports... |
Important Information For Patients From Susan G. Komen For The Cure® And The College Of American Pathologists Recent media reports of potential misdiagnosis of early-stage breast cancer may frighten women away from breast cancer screening that could save their lives. Rather than shying away from screening, women should know the questions to ask and be confident about weighing their options, according to Susan G... |
Abraxis BioScience And Specialised Therapeutics Announce Approval To Market ABRAXANE For Metastatic Breast Cancer In New Zealand Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy... |
More Funding Needed For Breast, Cervical Cancer Detection Program, Advocates Say During an event to mark its 20th anniversary, advocates of the National Breast and Cervical Cancer Early Detection Program on Tuesday expressed frustration that the program has not been extended to more low-income women and urged Congress to increase funding, CQ HealthBeat reports... |
Breakthrough Breast Cancer Identifies Potential New Treatment Which Could Help 800 Scottish Women Each Year Scientists from the Breakthrough Breast Cancer Research Unit at the University of Edinburgh have discovered a potential new way to treat a common form of breast cancer which affects 800 Scottish women and 9,000 UK women each year. The team are the first to identify a gene's key role in causing the spread of HER2 positive breast cancer to other parts of the body... |
Cytori Gains Stem Cell Device Approval In Europe For Breast Cancer Reconstruction And Soft Tissue Repair Cytori Therapeutics (NASDAQ: CYTX) received expanded European approval (CE Mark) for its Celution® System, a medical device that extracts and separates stem and regenerative cells from a patient's own fat tissue... |
Additional Research Funds To TGen From The Marilyn B. Gula Mountains Of Hope Foundation To Support Advanced Breast Cancer Research And Treatment The Marilyn B. Gula Mountains of Hope Foundation continues its fight against advanced breast cancer with a $50,000 donation to the Phoenix-based Translational Genomics Research Institute (TGen), for a total contribution over two years of $300,000... |
1,500 Canadian Women To Take Part In 5-Year Breast Cancer Survivorship Study Over the next five years, a diverse, multi-disciplinary team of researchers led by Dr. Kerry Courneya of the University of Alberta and Dr. Christine Friedenreich of Alberta Health Services will conduct a series of five large research projects to probe the impacts of physical activity on breast cancer thanks to a $2... |
Women In Their 40s Have Lower Mammographic Tumor Detectability The reduced effectiveness of mammographic screening in women in their forties is primarily due to lower detectability instead of faster tumor growth rate, according to a study published online July 27 in The Journal of the National Cancer Institute... |
| RSS integration by RSSinclude |